fludarabine has been researched along with Rheumatoid Arthritis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donaldson, SL; McGonagle, DG; Owen, RG | 1 |
| Alexandrova, IY; Grishina, GV; Kozlov, VA; Makarov, SV; Minaev, YL; Mishchenko, OV; Rossiev, VA; Semagina, OV | 1 |
| Barr, WG; Brush, M; Burt, RK; Oyama, Y; Quigley, K; Statkute, L; Traynor, A; Verda, L; Yaung, K | 1 |
| Kneba, M; Moosig, F; Schoch, R | 1 |
| Boumpas, DT; Davis, JC; Fessler, BJ; Fleisher, TA; Klippel, JH; McInnes, IB; Pillemer, S; Tassiulas, IO; Wilder, R; Yarboro, CH | 1 |
| Bambara, LM; Biasi, D; Caramaschi, P; Carletto, A | 1 |
| Kashyap, A; Snowden, J | 1 |
2 review(s) available for fludarabine and Rheumatoid Arthritis
| Article | Year |
|---|---|
[T-large granular lymphocyte leukaemia. An important differential diagnosis to Felty's syndrome].
Topics: Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Felty Syndrome; Humans; Immunosuppressive Agents; Leukemia, Lymphoid; Leukemia, T-Cell; Methotrexate; Vidarabine | 2006 |
Considerations in the selection of an appropriate conditioning regimen for the treatment of rheumatoid arthritis by autologous peripheral blood stem cell transplantation.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Busulfan; Carmustine; Cyclophosphamide; Cytarabine; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Melphalan; Podophyllotoxin; Radiotherapy, Adjuvant; Transplantation Conditioning; Transplantation, Autologous; Vidarabine | 2001 |
2 trial(s) available for fludarabine and Rheumatoid Arthritis
| Article | Year |
|---|---|
High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis.
Topics: Antigens, CD; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Leukocytes, Mononuclear; Lymphocyte Count; Male; Middle Aged; Phenotype; Platelet Count; Time Factors; Treatment Outcome; Vidarabine | 1998 |
Unsuccessful treatment with fludarabine in four cases of refractory rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Disease Progression; Female; Humans; Immunosuppressive Agents; Lymphocyte Count; Male; Middle Aged; Prednisone; Treatment Failure; Vidarabine | 2000 |
3 other study(ies) available for fludarabine and Rheumatoid Arthritis
| Article | Year |
|---|---|
Prolonged remission of marginal zone lymphoma in a patient with rheumatoid arthritis treated with anti-tumor necrosis factor agents.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Cyclophosphamide; Etanercept; Female; Humans; Immunoglobulin G; Infliximab; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Receptors, Tumor Necrosis Factor; Remission Induction; Rituximab; Treatment Outcome; Tumor Necrosis Factor-alpha; Vidarabine | 2014 |
[The role and place of high-dose immunosuppressive therapy and autologous transplantation of hematopoietic stem cells for autoimmune diseases].
Topics: Adult; Age Factors; Antilymphocyte Serum; Arthritis, Rheumatoid; Cyclophosphamide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Melphalan; Multiple Sclerosis; Patient Acuity; Retrospective Studies; Transplantation, Autologous; Treatment Outcome; Vidarabine | 2016 |
Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antirheumatic Agents; Arthritis, Rheumatoid; CD3 Complex; Cyclophosphamide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Middle Aged; Sialic Acid Binding Ig-like Lectin 3; Transplantation Chimera; Vidarabine | 2004 |